Evommune (EVMN.US) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Oct18

Evommune, Inc. released FY2025 Q2 earnings on October 17, 2025 (EST) with actual revenue of USD 0 and EPS of USD -1.0241

03:00

Evommune, Inc. released FY2024 Semi-Annual Earnings on October 17, 2025 (EST) with actual revenue of USD 7 M and EPS of USD -20.2189

03:00

Evommune, Inc. released FY2024 Q2 earnings on October 17, 2025 (EST) with actual revenue of USD 0 and EPS of USD -18.3529

03:00

Evommune, Inc. released FY2025 Semi-Annual Earnings on October 17 (EST), actual revenue USD 3 M, actual EPS USD -18.2868

03:00

Oct10

Evommune, Inc. released FY2024 Q4 earnings on October 9, 2025 (EST) with actual revenue of USD 0 and EPS of USD -1.4684

03:00

Evommune, Inc. released FY2023 Annual Earnings on October 9, 2025 (EST), Actual Revenue: USD 5M, Actual EPS: USD -3.1898

03:00

Schedules & Filings

Schedules

Filings

Nov6

IPO(EST)

Listing Price USD 16

Oct17

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -13.57 M, EPS -1.0241

Oct9

Earning Release(EST)

FY2024 Q4 Earning Release (USD) Net Income -19.07 M, EPS -1.4684

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More